Announced

Completed

Charles River Laboratories completed the acquisition of Explora BioLabs for $295m.

Synopsis

Charles River Laboratories, a pharmaceutical company, completed the acquisition of Explora BioLabs, a provider of contract vivarium research services, for $295m. “With its presence in West Coast biohubs, the acquisition of Explora BioLabs complements our existing CRADL™ footprint and offers incremental opportunities to partner with an emerging, high-growth client base, many of which are engaged in cell and gene therapy development," James Foster, Charles River Laboratorie Chairman, President and CEO.

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Sort

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US